Newbury Pharmaceuticals AB

Newbury Pharmaceuticals AB (publ), a pharmaceutical company, produces and commercializes in-licensed specialty prescription drugs in Sweden, Denmark, Norway, and other Scandinavian countries. It offers oncology drugs, such as Lenalidomide, Sunitinib, Pazopanib, Lapatinib, Bosutinib, Lenvatinib, Enzalutamide, Nilotinib, Pomalidomide, Palbociclib, and Nintedanib; drugs for rare diseases, including Icatibant, Macitentan, Pirfenidone, and Teduglutide; neurology drugs, which include dimetylfumarat, lorazepam ER, teriflunomide, and fampridine; and drugs for various other therapeutic areas comprising Solifenacin + Tamsulosin, Liraglutide, Desmopressin ODT, Gabapentin ER, Rivaroxaban, Ticagrelor, Tofacitinib, and Varenicline. The company was incorporated in 2020 and is based in Lund, Sweden. Show More...